The expression of a constitutively active TGF-βR1 facilitates the formation of adenocarcinoma, whereas repression of the TGF-β pathway at the receptor level promotes the formation of squamous cell carcinoma29. The gene discussed is TGFB1; the disease is adenocarcinoma.